AVTX

6.7300.30%
SH

Solomon H. Snyder

Founder and Chairman of Scientific Advisory Board

Dr. Solomon H. Snyder, M.D. serves as Venture Partner of Catalio Capital Management, LP. He serves as a Venture Partner at Camden Partners Nexus Fund II, LP since 2019. He served as Vice Chairman of Scientific Board at Curio Wellness Corporation until December 2025. He also served as a Consultant to Guilford Pharmaceuticals Inc. since August 1993. Dr. Snyder is a Senior Advisor of the Scientific Advisory Board of Red Abbey Venture Partners, LLC. He is the Founder of Avalo Therapeutics, Inc and serves as its Chairman of Scientific Advisory Board. Dr. Snyder is a Co-Founder of Sova Pharmaceuticals, Inc. and serves as its Chairman of Scientific Advisory Board. He serves as Chairman of the Scientific Advisory Board at QRxPharma Limited. He served as an Advisory Board Member at Camden Partners Holdings, LLC till 2019. He serves as an Advisory Board Member at Camden Partners Holdings, LLC. He serves as a Member of Advisory Board at Camden Partners Exelixis Fund, LP. Dr. Snyder served as a Director of Guilford Pharmaceuticals Inc. since its inception in July 1993. Dr. Snyder was a Member of the Board of Directors of Scios, Inc. since April 2003. He helped start Nova Pharmaceuticals. He is Distinguished Service Professor of Neuroscience, Pharmacology and Psychiatry at the Johns Hopkins University School of Medicine. He has Received National Medal of Science award and 10 Honorary Doctorate Degrees. He is the Co-Founder of Nova Pharmaceuticals (merged with Scios, Guilford Pharmaceuticals and Cerecor NASDAQ: CERC). He is also the Scientific Advisory Board at Curio Wellness and Nova Pharmaceuticals. He served as Director of the Department of Neuroscience at The Johns Hopkins University School of Medicine from 1980 to 2006. In 1966, Dr. Snyder joined the staff of the Department of Pharmacology at The Johns Hopkins University School of Medicine. He received his undergraduate and medical training at Georgetown University and his psychiatric training at The Johns Hopkins University. He received Honorary Doctor of Science degrees from Northwestern University in 1981, Georgetown University in 1986, Ben Gurion University in 1990, Albany Medical College in 1998 and Technion University of Israel in 2002. He also holds BA from Georgetown University, MD from Georgetown University School of Medicine and Residency from Johns Hopkins Medicine.

Positions